Search

everythinglearnresearchcommunity

for

Search:↓

Skin problems are common in Bangladesh due to arsenic, prompt treatment of diabetic foot ulcers is crucial, maternal transmission causes most neonatal herpes, treatments for pediatric vasculitis are effective, the chickenpox vaccine works, more frequent UVB therapy helps psoriasis, certain jobs increase hand dermatitis risk, monoclonal antibodies treat psoriasis well, lifestyle affects psoriasis, alefacept improves psoriasis, imiquimod cream partially clears basal cell carcinoma, and iron may not help chronic hair loss.

Blood pressure drugs can cause skin lupus, but it improves after stopping the drug. The glycoprotein D vaccine works against genital herpes in some women, and the HPV-16 vaccine reduces HPV-16 infection and related diseases. More frequent light therapy clears psoriasis faster. A cream called imiquimod effectively treats a type of skin cancer. Iron supplements don't necessarily help with chronic hair loss in women.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

Experts discussed hair care, genetic hair defects, hair loss treatments, nail surgery, lupus treatments, skin infections, and cosmetic allergies.

PRP and HF-MSCs treatment improves hair growth, thickness, and density in androgenetic alopecia.

Hispanics in Northern Nevada had more COVID-19 cases but lower mortality than non-Hispanics.

The Polish Skindex-29 is a reliable and valid questionnaire for assessing the quality of life in Polish dermatology patients.

Most hospitalized internal medicine patients have undiagnosed skin problems and want them treated.

People with rheumatoid arthritis have a higher risk of developing alopecia areata.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Hair loss treatments work better with lifestyle changes.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

The document concludes that hair loss is common and can be treated with medications like minoxidil or surgical options, and it significantly affects people's psychological well-being.

A scalp blood vessel issue from hair transplant was successfully treated with a special liquid agent.

SA linked to mitochondrial issues and oxidative stress, while AGA involves disrupted hair growth genes.

Topical cetirizine 1% promotes hair growth in male androgenetic alopecia patients.

Telogen effluvium hair loss often resolves on its own in 3 to 6 months, but see a dermatologist if it persists.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Semecarpus anacardium leaf extract fights breast cancer and extends survival in mice.

Polyomavirus A2 infection in newborn mice caused hair follicle tumors.

Finasteride for hair loss may cause long-lasting side effects like impotence and low libido, but trials lack proper safety reporting.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Finasteride and dutasteride have little effect on Type 2 Diabetes risk.

Acne is linked to vitamin B12 deficiency.

Older age and existing health issues increase COVID-19 death risk.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.